Sanofi Reports Positive Late-Stage Results for Amlitelimab in Eczema Treatment 
U.S. Vaccine Policy Shifts Under RFK Jr. Create Uncertainty for Pharma and Investors 
NTSB Opens Investigation Into Waymo Robotaxis After School Bus Safety Violations in Texas 
BitGo IPO Prices Above Range, Raises $212.8M in Landmark Crypto Market Debut 
Tesla Plans FSD Subscription Price Hikes as Autonomous Capabilities Advance 
Exxon Mobil’s XTO Energy Explores Sale of Eagle Ford Shale Assets in South Texas 
Elon Musk Shares Bold Vision for AI, Robots, and Space at Davos 
FSU Criticizes ANZ Over Suncorp Bank Job Cuts Amid Post-Acquisition Commitments 
Ericsson Plans SEK 25 Billion Shareholder Returns as Margins Improve Despite Flat Network Market 
ByteDance Finalizes Majority U.S.-Owned TikTok Joint Venture to Avert American Ban 
Apple China Holiday Sale Offers Discounts Up to 1,000 Yuan on Popular Devices 
Baidu Shares Surge After Official Launch of Advanced Ernie 5.0 AI Model 
Microsoft Restores Microsoft 365 Services After Widespread Outage 
Intel Stock Slides Despite Earnings Beat as Weak Q1 Outlook Raises Concerns 
SoftBank Shares Surge as AI Optimism Lifts Asian Tech Stocks 
Goldman Sachs CEO David Solomon’s 2025 Pay Soars to $47 Million After Strong Deal-Making Year 
Apple Stock Jumps as Company Prepares Major Siri AI Chatbot Upgrade 
NEW YORK, May 05, 2017 -- Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of FTD Companies, Inc. securities (NASDAQ:FTD) from March 13, 2015 through March 14, 2017, inclusive (the “Class Period”). The lawsuit seeks to recover damages for FTD investors under the federal securities laws.
To join the FTD class action, go to http://rosenlegal.com/cases-1086.html or call Phillip Kim, Esq. or Kevin Chan, Esq. toll-free at 866-767-3653 or email [email protected] or [email protected] for information on the class action.
NO CLASS HAS YET BEEN CERTIFIED IN THE ABOVE ACTION. UNTIL A CLASS IS CERTIFIED, YOU ARE NOT REPRESENTED BY COUNSEL UNLESS YOU RETAIN ONE. YOU MAY ALSO REMAIN AN ABSENT CLASS MEMBER AND DO NOTHING AT THIS POINT. YOU MAY RETAIN COUNSEL OF YOUR CHOICE.
According to the lawsuit, defendants throughout the Class Period made false and/or misleading statements and/or failed to disclose that: (1) FTD’s financial statements contained errors relating to the assessment of cross-border indirect taxes; (2) in turn, FTD lacked effective internal controls over financial reporting; (3) FTD had overstated the benefits of the Provide acquisition; and (4) as a result, FTD’s public statements were materially false and misleading at all relevant times. When the true details entered the market, the lawsuit claims that investors suffered damages.
A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than May 19, 2017. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation. If you wish to join the litigation, go to http://rosenlegal.com/cases-1086.html or to discuss your rights or interests regarding this class action, please contact Phillip Kim, Esq. or Kevin Chan, Esq. of Rosen Law Firm toll free at 866-767-3653 or via e-mail at [email protected] or [email protected].
Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm or on Twitter: https://twitter.com/rosen_firm.
Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation.
Contact Information: Laurence Rosen, Esq. Phillip Kim, Esq. Kevin Chan, Esq. The Rosen Law Firm, P.A. 275 Madison Avenue, 34th Floor New York, NY 10016 Tel: (212) 686-1060 Toll Free: (866) 767-3653 Fax: (212) 202-3827 [email protected] [email protected] [email protected] www.rosenlegal.com
